Please login to the form below

Not currently logged in
Email:
Password:

ABPI names latest Code breaches

Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded

Bayer Healthcare, Chiesi and Eli Lilly and Company have been named in advertisements for breaches of the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice, while Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare, Chiesi, Eli Lilly were found to have breached Clause 2 of the ABPI Code of Practice - administered by the Prescription Medicines Code of Practice Authority (PMCPA) - bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Meanwhile Bayer Schering Pharma has been reprimanded for failing to include prescribing information.

The breaches will be highlighted in advertisements in the medical, pharmaceutical and nursing press.

The PMCPA May Code of Practice Review (PDF) has further information on the breaches of the Code.

31st May 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...